NewsRx

Search our medical news database

Kaposi Sarcoma

Anti-HHV8 immunostaining should be performed in lymphangioendothelioma patients

Published in Cancer Weekly, December 16th, 2003

Early anti-HHV8 immunostaining should be performed to differentiate lymphangioendothelioma from Kaposi sarcoma.

In the Annals de Pathologie, scientists in France described "two cases of early Kaposi sarcoma illustrating the risk of misdiagnosis."

"Both lesions showed histological features and clinical aspects that mimicked lymphangioendothelioma," according to V. Audard and coauthors at Hopital Necker-Enfants Malades. "The diagnosis of lymphangioma-like Kaposi sarcoma was not made until a few years later, after the lesions had become more extensive and bilateral."

"Because of this evolution which is uncommon for a...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook